SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-99-006867
Filing Date
1999-07-28
Accepted
1999-07-28 00:00:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #8 TO SCHEDULE 13D SC 13D/A 13931
2 AGREEMENT DATED 07-01-99 EX-99.1 33704
3 GUARANTY EX-99.2 15130
4 SHARE PURCHASE AGREEMENT EX-99.4.A 127012
5 AMENDMENT TO SHARE PURCHASE AGREEMENT EX-99.4.B 4957
6 LIST OF BIOCHEMS DIRECTORS EX-99.5 7244
  Complete submission text file 0000950123-99-006867.txt   204325
Mailing Address
Business Address 10150 OLD COLUMBIA ROAD COLUMBIA MD 21046 4103097100
NORTH AMERICAN VACCINE INC (Subject) CIK: 0000856573 (see all company filings)

IRS No.: 980121241 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49421 | Film No.: 99671318
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Filed by) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances